What’s the FDA Time Limit for Taking GLP-1 Meds?

“GLP-1 receptor agonists are approved for long-term use as stopping them may lead to regaining of lost weight.”

If you suddenly stop taking a GLP-1 medication, your appetite may return to previous levels, especially for those who failed to make the needed lifestyle changes in regards to what they had been eating. For obese and overweight individuals with weight-related disorders, regain can be a challenge unless strict dietary and exercise habits are adopted to replace the GLP-1 medication. That’s why your doctor may adjust dosages slowly after your target weight is reached.

Generally speaking, these incretin mimetics are approved for chronic management of Type 2 diabetes and obesity, which means most patients can continue prescription GLP-1s indefinitely under a doctor’s care. It is this professional review of the patient’s history and collective results that ensure long-term use of a particular GLP-1 at a specified dosage is both safe and effective. So, synthetic incretins can be used similar to cholesterol or blood pressure medications.

Whether you were prescribed a single (liraglutide, semaglutide) or dual-action (tirzepatide) GLP-1 agonist, it is your doctor and not the FDA who decides how long you should take that formulation and dosage based on your goals for improving your metabolic health and wellness as well as any changes in tolerance. Nonetheless, since suddenly stopping the medication will typically lead to the return of a more natural appetite, you need to work with your weight loss coach one-on-one to adopt more favorable lifestyle choices for long-term success.

Should you discard unused semaglutide after 28 days?

For starters, semaglutide is a peptide-based drug that naturally breaks down when exposed to air, light and temperature changes, which means it will not work as effectively for either blood sugar control or weight loss. Moreover, there is a contamination risk every time you puncture the septum diaphragm on the vial or multi-dose pen as microscopic bacteria can be introduced that increase one’s risk of more serious skin infections. Even if the 28 days have not passed, experts say you should immediately discard semaglutide if you notice the medication is discolored, cloudy, or contains floating particles.

Can an expired multi-dose pen of semaglutide make you sick?

While the most common negative outcome of using expired semaglutide is that the incretin mimetic simply stops working as well due to chemical breakdown, any time you inject a compromised drug solution, it poses distinct health risks. Since semaglutide formulations contain preservatives, it becomes a breeding ground for bacteria and fungi that can cause injection-site infections, abscesses, or even systemic illnesses. In addition to sudden blood sugar spikes and crashes, the molecular degradation of chemical bonds can release harmful byproducts that may boost side effects or trigger severe allergic reactions.

Can chemical breakdown decrease semaglutide’s effectiveness?

Yes, this glucagon-like peptide-1 receptor agonist loses potency, as it is a peptide hormone analog comprised of a delicate chain of amino acids. Changes overtime in temperature and moisture cause the drug to undergo hydrolysis and oxidation that break the peptide’s molecular bond. Because its molecular shape is no longer correct, it cannot properly bind to the GLP-1 receptors in the person’s gut/brain axis pathways. This can lead to a loss of biological signaling needed to slow gastric emptying, trigger insulin secretion, and suppress appetite that can be reduced in potency by 10% to 30% within just days of semaglutide’s expiration date.

Why Hundreds of  FDA Warning Letters Were Recently Issued?

During the GLP-1 drug shortages that lasted for less than three years, compounded alternatives were legally permissible under FDA discretion. However, once the FDA officially declared the tirzepatide and semaglutide shortages resolved, mass-scale compounding of these drugs was no longer legally permitted. That’s why the FDA has issued over 100 warning letters to telehealth companies and compounders for making misleading claims about unapproved, compounded GLP-1s, including semaglutide and tirzepatide.

So, what risks are associated with non-FDA approved compounded GLP-1 drugs? Compounded drugs that are not FDA-approved bypass the rigorous safety and efficacy reviews required by the consumer health agency and can carry significant risks including dosing inaccuracies, unknown ingredient impurities, and sterility concerns. Generally speaking, non-approved compounded drugs do not contain the exact active ingredients or function identically to generic versions of brand-name medications. To date, the FDA has received over 1700 adverse reports.

Are there exceptions that still allow prescribing compounded GLP-1 drugs?

Yes, there are authorized exceptions that may still allow compounded GLP-1 receptor agonists to be prescribed and filled by state-licensed 503A compounding pharmacies based on patient-specific prescriptions. However, in such cases, the professional clinical prescriber must correctly document each specific patient’s need, such as compounding a GLP-1 formulation without an inactive-ingredient that the patient is allergic to. The FDA has said that the cost of brand-name products or patient convenience are not considered a qualifying reason alone.

_______________________

Based on the individual’s specific needs, prescriptive GLP-1 medications may be continued indefinitely whether they are used for blood sugar control, as a weight-loss drug, or both. But, most medications used to treat chronic conditions require long-term use with sustainable dosing strategies to prevent the reversing of drug benefits related to suddenly not taking the drug. Since older patients naturally lose muscle mass and bone density, GLP-1 medications may need to be prescribed as a temporary treatment due to elderly-specific barriers. At Metabolic Research Center Westminster, our goal is to provide the GLP-1 support needed to create a customized program that preserves crucial muscle mass, limits the common side effects of using a GLP-1 receptor agonist, and produces the changes your body needs for sustainable weight control.